The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $108.45

Today's change+2.91 +2.76%
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $108.45

Today's change+2.91 +2.76%
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.

Gilead Sciences Inc Hits New 20-day High

Gilead Sciences Inc closed up sharply Friday, rallying (U.S.)$2.91 or 2.76% to (U.S.)$108.45 and setting a new 20-day high. Over the last five days, shares have gained 4.15% and 44.41% year to date. Shares have outperformed the S&P 500 by 33.27% during the last year.

Key company metrics

  • Open(U.S.) $105.89
  • Previous close(U.S.) $105.54
  • High(U.S.) $109.49
  • Low(U.S.) $104.64
  • Bid / Ask-- / --
  • YTD % change+44.41%
  • Volume21,210,335
  • Average volume (10-day)13,752,682
  • Average volume (1-month)14,679,439
  • Average volume (3-month)15,004,757
  • 52-week range(U.S.) $63.50 to (U.S.) $116.83
  • Beta0.71
  • Trailing P/E19.18×
  • P/E 1 year forward13.66×
  • Forward PEG0.51×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $5.65
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+45.34%

Based on its net profit margin of 45.34%, Gilead Sciences Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.85%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue6,0426,5354,9993,120
Total other revenue--------
Total revenue6,0426,5354,9993,120
Gross profit5,0555,6104,1862,262
Total cost of revenue987925813858
Total operating expense2,5632,1221,9561,923
Selling / general / administrative945614548513
Research & development630584595552
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income3,4794,4133,0431,197
Interest income (expense), net non-operating-103-102-76-73
Gain (loss) on sale of assets--------
Other--------
Income before tax3,3714,3072,9481,113
Income after tax2,7243,6502,223787
Income tax, total647657726326
Net income2,7313,6562,227791
Total adjustments to net income--------
Net income before extra. items2,7313,6562,227791
Minority interest7555
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,7313,6562,227791
Inc. avail. to common incl. extra. items2,7313,6562,227791
Diluted net income2,7313,6562,227791
Dilution adjustment--------
Diluted weighted average shares1,6371,6641,6801,710
Diluted EPS excluding extraordinary itemsvalue per share1.672.201.330.46
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.672.201.330.46